TARS
Tarsus Pharmaceuticals Inc
75.70$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | +70.6% | -54.7% | -32.4% | +948.6% | +146.7% | |
| – | +7,300.0% | +232.4% | +743.5% | -54.0% | +66.8% | +705.1% | +139.2% | |
| – | – | – | – | -54.8% | -36.2% | +973.1% | +147.3% | |
| – | +250.9% | +495.4% | +121.6% | +2.2% | +18.0% | +6.1% | +20.5% | |
| – | +153.0% | +619.4% | +210.8% | +77.0% | +78.7% | +195.4% | +80.1% | |
| – | +213.1% | +533.0% | +151.0% | +30.5% | +81.6% | +82.8% | +69.1% | |
| – | – | – | – | – | – | – | – | |
| – | – | +370.0% | +1,432.4% | -28.4% | +56.3% | +130.9% | +20.0% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +5,400.0% | -107.3% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.